Paradigm Biopharmaceuticals Temettü
Temettü kriter kontrolleri 0/6
Paradigm Biopharmaceuticals does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-39.1%
Geri Alım Getirisi
Toplam Hissedar Getirisi | -39.1% |
Gelecekteki Temettü Verimi | n/a |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Paradigm Biopharmaceuticals (ASX:PAR) Is In A Strong Position To Grow Its Business
Aug 22Here's Why We're Not At All Concerned With Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation
Apr 17Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth
Sep 21Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation
Jun 20Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth
Dec 02Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth
Jun 07Is Paradigm Biopharmaceuticals Limited (ASX:PAR) Trading At A 46% Discount?
Feb 22We're Not Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn
Jan 24Did You Participate In Any Of Paradigm Biopharmaceuticals' (ASX:PAR) Incredible 811% Return?
Dec 28When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?
Nov 29Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if PAR's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if PAR's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Paradigm Biopharmaceuticals Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (PAR) | n/a |
Pazarın Alt %25'i (AU) | 2.6% |
Pazarın En İyi %25'i (AU) | 6.1% |
Sektör Ortalaması (Biotechs) | 2.2% |
Analist tahmini (PAR) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate PAR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate PAR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate PAR's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as PAR has not reported any payouts.